Shares of Johnson & Johnson undefined were up 0.1% in trading on Friday after data from the Phase 1/2a clinical trial for its COVID-19 vaccine candidate was...
Positive results for J&J vaccine; child racial disparities seen
The company said it will start a Phase 3 trial of its vaccine among 10,000 volunteers in the U.K.
A huge international study of a COVID-19 vaccine that aims to work with just one dose is underway as Johnson & Johnson begins dosing up to 60,000 volunteers,
Coronavirus LIVE Updates: Johnson & Johnson began a 60,000-person trial of an experimental single-shot COVID-19 vaccine that, if proven effective, could simplify distribution of millions of doses comp
U.S. company Johnson & Johnson on Wednesday announced it has reached phase 3 clinical trials for its CCP virus vaccine candidate.
A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to...
Johnson & Johnson shares are up 2.3% in Wednesday’s pre-market trading after the healthcare company announced that it is kicking off with a
Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its COVID-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot.
Johnson & Johnson kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of doses
Fauci also said there's "growing optimism" that scientists will find one or more safe and effective vaccines by the end of the year or early 2021.
The health care giant is starting its trial two months after those of Moderna and the team of Pfizer and BioNTech, but it may have results from its trial...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE